Solitary skeletal osteosarcoma recurrence. Findings from the Cooperative Osteosarcoma Study Group

Pediatric Blood and Cancer

Volumn 56, Issue 5, 2011, Pages 771-776

  Franke, Markus ^a   Hardes, Jendrik ^b   Helmke, Knut ^c   Jundt, Gernot ^d   Jürgens, Heribert ^b   Kempf Bielack, Beate ^a   Kevric, Matthias ^a   Tunn, Per Ulf ^e   Werner, Mathias ^e   Bielack, Stefan ^a,b  

^a OLGAHOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Child; Osteosarcoma; Recurrence

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; TROFOSFAMIDE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CHILD; CLINICAL ARTICLE; DATA BASE; EVENT FREE SURVIVAL; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; OSTEOSARCOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952123932     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22864     Document Type: Article

References (19)

1. Ferrari S, Briccoli A, Mercuri M, et al. Postrelapse survival in osteosarcoma of the extremities: Prognostic factors for long-term survival. J Clin Oncol 2003; 21: 710-715.
2. Kempf-Bielack B, Bielack S, Jürgens H, et al. Osteosarcoma relapse after combined modality therapy: An analysis of unselected patients in the Osteosarcoma Study Group (COSS). J Clin Oncol 2005; 23: 559-568.
3. Aung L, Gorlick R, Healey JH, et al. Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma. J Clin Oncol 2003; 21: 342-348.
4. San-Julian M, Diaz-de-Rada P, Noain E, et al. Bone metastases from osteosarcoma. Int Orthop 2003; 27: 117-120.
5. Bacci G, Longhi A, Bertoni F, et al. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: The Rizzoli experience in 52 patients. Acta Orthop 2006; 77: 938-943.
6. Jaffe N, Pearson P, Yasko AW, et al. Single and multiple metachronous osteosarcoma tumors after therapy. Cancer 2003; 98: 2457-2466.
7. Brandal P, Bjerkehagen B, Bruland OS, et al. Synchronous and metachronous skeletal osteosarcoma: The Norwegian Radium Hospital experience. Acta Oncol 2009; 48: 1165-1172.
8. Bielack S, Kempf-Bielack B, Schwenzer D, et al. Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative Osteosarcoma Study Group COSS of 925 patients. Klin Padiatr 1999; 211: 260-270.
9. Bielack S, Jürgens H, Jundt G, et al. Osteosarcoma: The COSS experience. Cancer Treat Res 2009; 152: 289-308.
10. Bielack S, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk. An analysis of 1072 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2002; 20: 776-790.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
12. Mantel M. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
13. Kalbermatten DF, Windisch W, Siebenrock KA. High-grade metachronous osteosarcoma. A case report over a 23-year period. Acta Orthop Belg 2000; 66: 507-513.
14. Bielack S, Kempf-Bielack B, Heise U, et al. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group. J Clin Oncol 1999; 17: 1164.
15. Tabone MD, Terrier P, Pacquement H, et al. Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: A study of 23 cases. J Clin Oncol 1999; 17: 2789-2795.
16. Hawkins DS, Arndt CA. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Cancer 2003; 98: 2447-2456.
17. DeLaney TF, Park L, Goldberg SI, et al. Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys 2005; 61: 492-498.
18. Schwarz R, Bruland O, Cassoni A, et al. The role of radiotherapy in osteosarcoma. Cancer Treat Res 2009; 152: 147-165.
19. Bielack S, Carrle D, Casali PS. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20: iv137-iv139.